WAYNE, Pa., June 6, 2017 /PRNewswire/ -- Egalet Corporation (EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative treatments for pain and other conditions, today announced one of the largest payers in the United States will provide coverage of ARYMO® ER (morphine sulfate) extended-release tablets, for oral use –CII.